Cargando…
Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease
BACKGROUND: The role of single nucleotide polymorphisms (SNPs) associated with inflammatory bowel disease (IBD) is gaining interest. With the advent of novel therapies, personalized treatment in IBD is a future goal. We wondered whether IBD-associated SNPs are able to predict response to anti-TNFα t...
Autores principales: | Nuij, V. J. A. A., Peppelenbosch, M. P., van der Woude, C. J., Fuhler, G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725822/ https://www.ncbi.nlm.nih.gov/pubmed/29228965 http://dx.doi.org/10.1186/s12967-017-1355-9 |
Ejemplares similares
-
A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models
por: van der Giessen, Janine, et al.
Publicado: (2019) -
Peripheral Neutrophil Functions and Cell Signalling in Crohn`s Disease
por: Somasundaram, Rajesh, et al.
Publicado: (2013) -
Association of ATG16L1 gene haplotype with inflammatory bowel disease in Indians
por: Pugazhendhi, Srinivasan, et al.
Publicado: (2017) -
Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
por: Lie, Mitchell R. K. L., et al.
Publicado: (2018) -
Defective ATG16L1-mediated removal of IRE1α drives Crohn’s disease–like ileitis
por: Tschurtschenthaler, Markus, et al.
Publicado: (2017)